CLARIVATE PLC (CLVT)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-05-05

Key Insights

  • Henry Levy, President of LS&H at Clarivate, executed a stock transaction involving 19,893 ordinary shares on May 1, 2026, with shares withheld for tax purposes upon RSU vesting rather than a voluntary purchase or sale.
  • The transaction price of $2.79 per share represents a routine equity compensation vesting event, not a discretionary insider trading activity that would signal confidence or concern about the company's valuation.
  • Following this transaction, Levy maintains beneficial ownership of 983,373 ordinary shares in direct form, indicating substantial executive equity stake in the company.
Quarterly Report Filed: 2026-04-29

Key Insights

  • The filing shows extensive derivative instruments and hedging activities across interest rate swaps and currency swaps, indicating active management of financial risks related to the company's debt structure and international operations.
  • Multiple debt instruments are present including Senior Secured Notes (2026, 2028), Senior Notes (2029), and Term Loan Facilities, suggesting a complex capital structure that requires careful refinancing management in the coming quarters.
  • The XBRL structured data indicates detailed tracking of recurring revenues, subscription revenues, and transactional revenues by segment, reflecting a software/information services business model with recurring revenue streams.
  • Revenue composition includes subscription and recurring revenue streams which typically command higher valuations, though the exact Q1 2026 financial metrics are truncated in the provided document, limiting ability to assess specific performance trends.
Current Report Filed: 2026-04-29

Key Insights

  • Clarivate announced Q1 2026 earnings results on April 29, 2026, providing updated financial performance and revenue metrics for the first quarter ended March 31, 2026.
  • The company disclosed supplemental information including detailed revenue, earnings, and forward guidance through Regulation FD disclosure, indicating management's intent to provide comprehensive transparency to investors.
  • The filing was executed by Jonathan M. Collins, Executive Vice President & Chief Financial Officer, confirming proper authorization and accountability for the disclosed financial information.
  • Both the earnings press release and supplemental materials were furnished rather than filed, limiting their incorporation into future SEC filings and reducing associated liability exposure under Section 18 of the Securities Exchange Act.
Insider Trading Filed: 2026-04-02

Key Insights

  • Insider Kenneth L. Cornick, a director of Clarivate PLC, acquired 11,363 ordinary shares of the company on March 31, 2026, demonstrating his confidence in the company.
  • Cornick also holds an indirect beneficial ownership of 1,100,000 ordinary shares through Cornick Family Investor, LLC, which he controls with his spouse.
  • The acquisition price of $2.53 per share suggests Cornick believes the stock is undervalued and has growth potential.
Insider Trading Filed: 2026-04-02

Key Insights

  • Jane L Okun Bomba, a director at Clarivate PLC, acquired 11,363 ordinary shares on March 31, 2026, at a price of $2.53 per share, indicating her continued confidence in the company.
  • Bomba also sold 621 shares to cover tax withholding, maintaining a total beneficial ownership of 240,264 shares plus 49,750 shares held indirectly through a trust.
  • The transaction was made as part of Bomba's director compensation, with the share award replacing a cash retainer of $28,750, aligning her interests with shareholders.
Insider Trading Filed: 2026-04-02

Key Insights

  • Insider Andrew Miles Snyder acquired 20,256 ordinary shares of Clarivate PLC (CLVT) on March 31, 2026, indicating his confidence in the company's prospects.
  • Snyder also holds significant indirect beneficial ownership in Clarivate through various entities, including Cambridge Information Group Inc. and related LLCs, suggesting he has a substantial stake in the company.
  • The transaction was made in lieu of cash retainer for Snyder's services as a board member, suggesting he prefers to receive equity compensation rather than cash.
Current Report Filed: 2026-03-26

Key Insights

  • Clarivate Plc has adopted an amended and restated executive severance plan, which expands the eligibility criteria and severance benefits for key executives.
  • The new plan provides for full vesting of outstanding restricted stock units upon a qualifying termination of employment, either with or without a change in control.
  • The addition of 'good reason' termination in a change in control scenario suggests increased focus on retaining key talent during potential corporate transactions.
Insider Trading Filed: 2026-03-17

Key Insights

  • Insider Mourad Maroun S., the President of IP, acquired a significant number of 377,358 ordinary shares in Clarivate PLC, indicating management's confidence in the company's future prospects.
  • Mourad Maroun S. also holds an indirect beneficial ownership of 105,000 ordinary shares through his spouse, suggesting a substantial personal investment in the company.
  • The transaction was executed at a price of $0 per share, potentially indicating the shares were acquired through an equity compensation plan or other non-market transaction.
Insider Trading Filed: 2026-03-17

Key Insights

  • Michael M. Easton, the Senior VP and CAO of Clarivate PLC, made a large direct purchase of 282,075 ordinary shares on March 15, 2026, potentially indicating his confidence in the company's prospects.
  • Easton also gifted 26,500 shares to a charitable organization on March 13, 2026, which could signal his philanthropic intentions.
  • The company withheld 30,456 shares from Easton's account on March 15, 2026 to cover tax obligations, suggesting a vesting of restricted share units.
Insider Trading Filed: 2026-03-17

Key Insights

  • Insider William E. Graff, the EVP and Chief Information Officer, acquired 254,716 ordinary shares of Clarivate PLC, indicating confidence in the company's future performance.
  • Graff also sold 23,838 shares to cover tax obligations, suggesting he continues to hold a sizable stake in the company.
  • The transaction represents a significant increase in Graff's direct ownership, potentially signaling his belief in the company's growth prospects.
Insider Trading Filed: 2026-03-17

Key Insights

  • Matitiahu S. Shem Tov, the Chief Executive Officer of Clarivate PLC, acquired 1,132,075 ordinary shares of the company on March 15, 2026 at no cost, indicating a significant increase in his ownership stake.
  • Shem Tov also disposed of 125,471 ordinary shares on the same date, likely to cover tax obligations related to the share acquisition, suggesting a continued commitment to the company.
  • The reporting person holds a total of 2,338,415 ordinary shares directly, along with an additional 320,603 shares held indirectly through the IBI Trust Management, indicating a substantial insider ownership position.
Insider Trading Filed: 2026-03-17

Key Insights

  • Insider Veinstein Bar, the President of Analytics & Growth, acquired 377,358 ordinary shares of Clarivate PLC, suggesting confidence in the company's future prospects.
  • The share acquisition represents a significant 30% increase in Veinstein's direct beneficial ownership, indicating a positive outlook on the company's performance.
  • Insider trading activity, such as this open-market purchase, can provide insight into management's confidence in the company's long-term growth and strategy.
Insider Trading Filed: 2026-03-17

Key Insights

  • The reporting person, Jonathan Mark Collins, acquired 471,698 ordinary shares in Clarivate PLC on March 15, 2026, indicating an increase in his ownership stake in the company.
  • Collins also disposed of 43,987 shares to cover tax withholding obligations and transferred 35,741 shares to his former spouse as part of a divorce settlement.
  • The insider transactions suggest Collins is aligning his personal holdings with the company's long-term performance, despite the partial reduction in his direct ownership.
Insider Trading Filed: 2026-03-17

Key Insights

  • Henry Levy, the President of Life Sciences & Health at Clarivate PLC, has acquired 377,358 ordinary shares in the company through a stock award, indicating potential confidence in the company's future performance.
  • Levy also disposed of 35,402 shares to cover tax obligations, suggesting he is retaining a substantial portion of his equity stake in the company.
  • The timing of this transaction, which occurred in March 2026, may provide insight into the company's recent performance and future growth prospects.
Annual Report Filed: 2026-02-24

Key Insights

  • Clarivate PLC reported solid revenue growth across its subscription, re-occurring, and transactional revenue streams, indicating the company's business model continues to perform well.
  • The company's balance sheet remains strong, with a healthy cash position and manageable debt levels, providing financial flexibility to invest in growth initiatives.
  • Clarivate's ongoing portfolio optimization, including the planned divestment of non-core assets, suggests the company is focused on streamlining its operations and improving its strategic alignment.
Current Report Filed: 2026-02-24

Key Insights

  • Clarivate PLC reported strong Q4 2025 earnings, with revenue growth and improved profitability. The company provided positive guidance for the next fiscal year.
  • The filing indicates there were no major leadership changes or material agreements announced, suggesting operational continuity.
  • Clarivate's stock appears to be in a stable position, with the earnings release and supplementary information providing transparency for investors.
Insider Trading Filed: 2026-02-20

Key Insights

  • The reporting person, Jonathan Mark Collins, acquired 35,573 ordinary shares of Clarivate PLC through the vesting of performance share units granted in 2023.
  • The reporting person also sold 17,396 shares to cover tax liability incident to the vesting, indicating a partial liquidation of his equity position.
  • The reporting person continues to hold 795,224 ordinary shares, representing his ongoing commitment and alignment with Clarivate's long-term success.
Insider Trading Filed: 2026-02-20

Key Insights

  • Insider Henry Levy, President of Life Sciences & Health, acquired 36,847 ordinary shares of Clarivate PLC, indicating his confidence in the company's prospects.
  • Levy also disposed of 18,115 shares to cover tax liabilities associated with the vesting of performance share units, suggesting he is holding a significant portion of his ownership.
  • The transaction suggests Levy's alignment with Clarivate's long-term growth strategy, as the performance share units were granted in 2023 and vested upon the achievement of certain performance conditions.
Insider Trading Filed: 2026-02-20

Key Insights

  • Michael M. Easton, the Senior VP and CAO of Clarivate PLC, acquired 7,114 ordinary shares and disposed of 3,521 shares through a tax withholding transaction on February 18, 2026.
  • The transaction was related to the vesting of Easton's performance share units granted in 2023, indicating his long-term incentive alignment with the company.
  • Easton's total beneficial ownership of Clarivate shares following the reported transaction is 497,764, suggesting he maintains a significant stake in the company.
Insider Trading Filed: 2026-02-20

Key Insights

  • Insider Bar Veinstein, the President of Analytics and Governance, acquired 36,847 ordinary shares of Clarivate PLC (CLVT), indicating management's confidence in the company's prospects.
  • The shares were acquired through the settlement of performance share units granted in 2023, suggesting the company met its performance targets.
  • Veinstein's increased stake in the company, now totaling 885,658 shares, aligns his interests with those of shareholders and signals his long-term commitment to Clarivate PLC.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.